Dare Bioscience (DARE) Return on Capital Employed [ROCE] (2017 - 2026)
Dare Bioscience (DARE) posted Return on Capital Employed [ROCE] of -113.71% for Q2 2026.
Powered by 
Analysis
Dare Bioscience (DARE) Return on Capital Employed [ROCE] (2017 - 2026) Analysis & Trends
For FY2025, Dare Bioscience's Return on Capital Employed [ROCE] came in at -376.23%, up 29457.99 percentage points from FY2024.
- Annual Return on Capital Employed [ROCE] shows a four-year change of -126.21 percentage points (FY2021 to FY2025).
- In prior years, Dare Bioscience's Return on Capital Employed [ROCE] was -29834.22% in FY2024 (-29577.96 pp), -256.26% in FY2023 (-83.74 pp), -172.52% in FY2022 (+77.51 pp) and -250.02% in FY2021.
- The Q2 2026 figure stands as the highest quarterly Return on Capital Employed [ROCE] since Q3 2022.
- The strongest year-over-year quarter for Return on Capital Employed [ROCE] in the past five years was Q3 2021, with a gain of 14836.69 percentage points; the weakest was Q3 2025, with a drop of 2394.65 percentage points.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,230.11 Bn | 1,198.70 Bn | 19.71 Bn | 46.74% |
| 2 | Johnson & Johnson | 644.39 Bn | 564.25 Bn | 17.30 Bn | 17.52% |
| 3 | AbbVie | 503.52 Bn | 476.68 Bn | 12.70 Bn | 17.92% |
| 4 | Merck | 363.29 Bn | 317.72 Bn | 12.21 Bn | 6.28% |
| 5 | Novartis Ag | 298.23 Bn | 262.62 Bn | 11.24 Bn | 19.32% |
| 6 | Astrazeneca | 267.53 Bn | 241.29 Bn | 12.86 Bn | 16.76% |
| 7 | Amgen | 241.80 Bn | 197.20 Bn | 7.24 Bn | 16.66% |
| 8 | Gilead Sciences | 195.07 Bn | 169.19 Bn | 6.22 Bn | -5.97% |
| 9 | Pfizer | 173.33 Bn | 120.28 Bn | 10.94 Bn | 11.86% |
| 10 | Dare Bioscience | 9.86 Mn | -55.60 Mn | -132,343.00 | -113.71% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -113.71% |
| Dec 31, 2025 | -170.99% |
| Sep 30, 2025 | -2,697.31% |
| Sep 30, 2024 | -302.66% |
| Jun 30, 2024 | -724.55% |
| Dec 31, 2023 | -1,151.17% |
| Jun 30, 2023 | -1,951.69% |
| Mar 31, 2023 | -245.86% |
| Dec 31, 2022 | -202.78% |
| Sep 30, 2022 | -88.06% |
| Jun 30, 2022 | -89.56% |
| Mar 31, 2022 | -110.17% |
| Dec 31, 2021 | -107.76% |
| Sep 30, 2021 | -238.63% |
| Jun 30, 2021 | -493.27% |
| Mar 31, 2021 | -1,054.00% |
| Sep 30, 2020 | -15,075.32% |
| Jun 30, 2020 | -564.01% |
| Mar 31, 2020 | -377.26% |
| Dec 31, 2019 | -28,691.48% |
API Access
Dare Bioscience Return on Capital Employed [ROCE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=DARE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-capital-employed-[roce]", "ticker": "DARE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=DARE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();